A study to find out whether the medication pasireotide is absorbed and processed the same way when given under the skin using either a reusable pen or a syringe in healthy subjects
SOM230-RECAG-PK-0605
Phase 1 other active
Quick answer
A study to find out whether the medication pasireotide is absorbed and processed the same way when given under the skin using either a reusable pen or a syringe in healthy subjects for Post-bariatric hypoglycaemia is a Phase 1 program (other) at Recordati Ireland with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Recordati Ireland
- Indication
- Post-bariatric hypoglycaemia
- Phase
- Phase 1
- Modality
- other
- Status
- active